Paper33348673
The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction.
Campelj DG and 5 others. Cancers (Basel), 2020. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction. Papers, record 33348673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33348673
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References103
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31968693 | Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome. | Molecules | 2020 | https://conductscience.org/library/papers/31968693 | PubMed |
| 2 | 23530101 | Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23530101 | PubMed |
| 3 | 32069876 | Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32069876 | PubMed |
| 4 | 24442322 | The role of mTORC1 in regulating protein synthesis and skeletal muscle mass in response to various mechanical stimuli. | Rev Physiol Biochem Pharmacol | 2014 | https://conductscience.org/library/papers/24442322 | PubMed |
| 5 | 17470860 | Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17470860 | PubMed |
| 6 | 32393676 | The flipside of the TOR coin - TORC2 and plasma membrane homeostasis at a glance. | J Cell Sci | 2020 | https://conductscience.org/library/papers/32393676 | PubMed |
| 7 | 29520731 | Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics. | Clin Pharmacokinet | 2018 | https://conductscience.org/library/papers/29520731 | PubMed |
| 8 | 7867226 | Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. | Clin Exp Pharmacol Physiol | 1994 | https://conductscience.org/library/papers/7867226 | PubMed |
| 9 | 22495301 | Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. | Nature | 2012 | https://conductscience.org/library/papers/22495301 | PubMed |
| 10 | 6087973 | Protein synthesis in muscle measured in vivo in cachectic patients with cancer. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6087973 | PubMed |
| 11 | 29089584 | ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass. | Sci Rep | 2017 | https://conductscience.org/library/papers/29089584 | PubMed |
| 12 | 26909043 | YAP-Mediated Mechanotransduction in Skeletal Muscle. | Front Physiol | 2016 | https://conductscience.org/library/papers/26909043 | PubMed |
| 13 | 27167634 | Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting? | Cancer Chemother Pharmacol | 2016 | https://conductscience.org/library/papers/27167634 | PubMed |
| 14 | 27807421 | Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways. | Front Physiol | 2016 | https://conductscience.org/library/papers/27807421 | PubMed |
| 15 | 31241984 | Distribution and activation of matrix metalloproteinase-2 in skeletal muscle fibers. | Am J Physiol Cell Physiol | 2019 | https://conductscience.org/library/papers/31241984 | PubMed |
| 16 | 32265741 | Skeletal Muscle Extracellular Matrix - What Do We Know About Its Composition, Regulation, and Physiological Roles? A Narrative Review. | Front Physiol | 2020 | https://conductscience.org/library/papers/32265741 | PubMed |
| 17 | 29991992 | Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia. | Eur J Transl Myol | 2018 | https://conductscience.org/library/papers/29991992 | PubMed |
| 18 | 21296615 | Definition and classification of cancer cachexia: an international consensus. | Lancet Oncol | 2011 | https://conductscience.org/library/papers/21296615 | PubMed |
| 19 | 30870215 | Resistance Exercise-Induced Hypertrophy: A Potential Role for Rapamycin-Insensitive mTOR. | Exerc Sport Sci Rev | 2019 | https://conductscience.org/library/papers/30870215 | PubMed |
| 20 | 21960318 | First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer. | J Cancer Res Clin Oncol | 2012 | https://conductscience.org/library/papers/21960318 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40790174 | Promoting mitochondrial fusion is protective against cancer-induced muscle detriments in males and females. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40790174 | PubMed |
| 40604314 | The role of NAD+ metabolism and its modulation of mitochondria in aging and disease. | NPJ Metab Health Dis | 2025 | https://conductscience.org/library/papers/40604314 | PubMed |
| 40468964 | Haptoglobin and Glutamine Synthetase May Biomark Cachexia Induced by Antiacute Myeloid Leukaemia Chemotherapy. | J Cachexia Sarcopenia Muscle | 2025 | https://conductscience.org/library/papers/40468964 | PubMed |
| 40381228 | Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy. | Redox Biol | 2025 | https://conductscience.org/library/papers/40381228 | PubMed |
| 39001580 | Dystrophin S3059 phosphorylation partially attenuates denervation atrophy in mouse tibialis anterior muscles. | Physiol Rep | 2024 | https://conductscience.org/library/papers/39001580 | PubMed |
| 38321934 | Tankyrase-1 regulates RBP-mediated mRNA turnover to promote muscle fiber formation. | Nucleic Acids Res | 2024 | https://conductscience.org/library/papers/38321934 | PubMed |
| 37751291 | Dimethyl fumarate modulates the dystrophic disease program following short-term treatment. | JCI Insight | 2023 | https://conductscience.org/library/papers/37751291 | PubMed |
| 34298829 | Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34298829 | PubMed |
| 34067869 | Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34067869 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EIF2S1 | 1965 | PubTator's text mining | https://conductscience.org/library/genes/1965 | NCBI Gene |
| FBXO32 | 114907 | PubTator's text mining | https://conductscience.org/library/genes/114907 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| TRIM63 | 84676 | PubTator's text mining | https://conductscience.org/library/genes/84676 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33348673
GET https://conductscience.org/api/papers/v1/33348673/references?page=2